Home » VC Deals Biotechnology
VC Deals Biotechnology
Google News : U.S. : All
- How are healthcare VCs in every sector handling Covid-19? - MedCity News
- Bristol Myers backs a European VC's record-setting biotech venture fund, which tops out at $600M - Endpoints News
- UPDATED: Oprah day in biotech: Regenacy gets $30M, Abbisko gets $70M, Castle Creek gets $75M - Endpoints News
- Seattle biotech startup Silverback Therapeutics raises $78.5M - GeekWire
- UPDATED: Vertex joins Merck, Pfizer — revamping multibillion-dollar trial strategy as biotech R&D crumbles - Endpoints News
- How demand for organic food is driving biotech innovation - Livemint
- Biogen's early R&D chief exits for ARCH and Bezos-backed anti-aging biotech - Endpoints News
- Turn on, tune in: New York biotech scores $15M+ in chemogenetics bet - Endpoints News
- The economy’s hurting. What does that mean for startups who plan to go public in 2020? - Fortune
- Exuma Biotech Corp., formerly F1 Oncology, raises $19M in Series E round - South Florida - New York Business Journal
- Coronavirus Turmoil Throws Biotechnology IPOs Into Question - The Wall Street Journal
- Venture Capital Investment Market Growing Popularity and Emerging Trends | Sequoia Capital, First Round Capital, UNION SQUARE VENTURES - Skyline Gazette
- The Funded: Offices closed, yes. Business closed, no. - New York Business Journal
- All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits - TechCrunch
- Chutes & Ladders—Urovant brings on Astellas alum Robinson as CEO - FierceBiotech
